Marijuana Stocks: GWPH Skyrockets on Morgan Stanley Coverage
by William White | April 22, 2014 1:27 pm
GW Pharmaceuticals (GWPH[1]) shares saw a huge jump[2] after Morgan Stanley’s coverage of the stock.
[3]
Morgan Stanley gave GWPH shares an “overweight” rating and set the stock’s target price at $103 a share. This would have GW Pharmaceuticals stock rising 123.72% from its previous close, reports WKRB News.
TheStreet’s[4] Jim Cramer has named GW Pharmaceuticals as his favorite cannabis stock and said that it will increase more than any stock besides Allergan (AGN[5]) on Tuesday.
Other firms that have weighed in on GWPH stock include Bank of America, Piper Jaffray and Leerink Swann. The general thoughts of these firms is that GW Pharmaceuticals stock is a buy, WKRB News notes.
GWPH shares were up 34% as of Tuesday afternoon.
More Stocks in the News
- MCD: McDonald’s Misses on Sales and Earnings[6]
- LMT: Lockheed Martin Beats Street, Boosts Outlook[7]
- LXK: Lexmark Stock Falls Hard on Forecast[8]
Endnotes:
- GWPH: http://studio-5.financialcontent.com/investplace/quote?Symbol=GWPH
- a huge jump: http://www.wkrb13.com/markets/294738/gw-pharmaceuticals-plc-coverage-initiated-at-morgan-stanley-gwph/
- [Image]: https://investorplace.com/wp-content/uploads/2014/04/gw-pharmaceuticals-logo.jpg
- TheStreet’s: http://www.thestreet.com/story/12674098/1/jim-cramers-stop-trading-gwph.html
- AGN: http://studio-5.financialcontent.com/investplace/quote?Symbol=AGN
- MCD: McDonald’s Misses on Sales and Earnings: https://investorplace.com/2014/04/mcd-mcdonalds-misses-sales-earnings/
- LMT: Lockheed Martin Beats Street, Boosts Outlook: https://investorplace.com/2014/04/lmt-lockheed-martin/
- LXK: Lexmark Stock Falls Hard on Forecast: https://investorplace.com/2014/04/lxk-lexmark/
Source URL: https://investorplace.com/2014/04/marjuana-stocks-gwph-gw-pharmaceuticals/